Digital health funding rebounds to $7.4B in first half of 2026, but concentration grows
U.S. digital health startups raised $7.4 billion across 244 deals in the first half of 2026, up from $6.4 billion a year earlier. Nineteen companies captured 45% of the capital through 20 rounds of $100 million or more. Rock Health also stopped labeling startups as 'AI-enabled' because the technology is now ubiquitous.
The funding rebound was unevenly distributed, with the median deal climbing to $14 million while mega-rounds dominated. Quarterly figures showed momentum slowing, with $4.2 billion in Q1 falling to $3.2 billion in Q2. Notable recipients included wearable maker Whoop at $575 million and Verily at $300 million, alongside mental health platforms Talkiatry and Grow Therapy.
Rock Health's decision to retire its "AI-enabled" category reflects how deeply embedded the technology has become. The firm now sees investors prioritizing four qualities: specialized domain knowledge, broader workflow ownership, direct service delivery, and durable partnerships. Mental health remained the top-funded clinical area, with obesity and weight management close behind.
The concentration of funding into fewer, larger rounds could reshape the competitive landscape for healthcare startups. Smaller companies may struggle to secure early-stage capital, potentially slowing innovation from newer entrants. Meanwhile, the emphasis on mental health and weight management suggests these areas will see accelerated product development, which could expand patient access to digital treatments. However, consolidation may also reduce choice for healthcare providers evaluating vendors, as fewer well-funded players dominate the market.